Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B: A Multicenter, Ambispective Cohort Study

NCT07555340 is registered in ClinicalTrials.gov with Juan Li as lead sponsor.

NCT NCT07555340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07555340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B: A Multicenter, Ambispective Cohort Study
Lead sponsor
Juan Li
Phase
Observational
Overall status
Active, not recruiting
Start date
December 30, 2024
Completion date
June 30, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b chronic